PTK2 and gastric cancer: Thus, the antagonist prevented the stabilization of integrin αβ1 clustering in gastric cancer cells, inhibiting phosphorylation of focal adhesion kinases (FAK) and its adaptor protein, paxillin, decreasing the invasion of gastric cancer cells.